Fitness 101

Expand Posts

6 Mistakes You’re Making With Your Contacts

scyther5/iStock/Thinkstock(NEW YORK) -- Proper contact lens hygiene is nothing to roll your eyes at: A new government report warns that bad habits (like wearing your lenses to bed) can lead to eye infections and possibly permanent injuries.The U.S. Centers for Disease Control and Prevention (CDC) examined more than 1,000 cases of contact lens-related infections reported to a federal database over the last decade, and found that nearly 1 in 5 of those infections resulted in eye damage—either a decline in vision, a scarred cornea, or the need for...
Share on Facebook

EpiPen Users Have Few Options for Generic or Alternate Drugs

iStock/Thinkstock(NEW YORK) -- The rising cost of EpiPens has led many to wonder whether there are cheaper options available on the market.The drug epinephrine has been around for decades, but the EpiPen, which is made by Mylan, has become the go-to epinephrine auto injector for many people in the U.S. There are multiple reasons why the EpiPen has become so popular, including diminishing competition and the fact that pharmacists in many states cannot automatically substitute a generic alternative.Recalls from Mylan's competitors have also boosted sales of...
Share on Facebook

Mother Discusses Fears for Child Born With Zika-Related Birth Defects

iStock/Thinkstock(MIAMI) -- A Venezuelan woman who gave birth in the U.S. to a daughter with birth defects related to Zika infection, said she is frustrated that there is so little known about the long-term effects of the virus.Maria Fernanda Ramirez Bolivar spoke to reporters Friday at Jackson Memorial Hospital in Miami, Florida, as her infant daughter Micaela spent most of the time sleeping in her arms.Bolivar's physician, Dr. Ivan Gonzalez, of UHealth Pediatric Infectious Diseases at Jackson Memorial Hospital, said Bolivar first come to the hospital...
Share on Facebook

Mylan CEO Heather Bresch Defends EpiPen Pricing as ‘Running a Business’

iStock/Thinkstock(NEW YORK) -- The chief executive of Mylan Pharmaceuticals, which makes the $600 EpiPen allergy treatment, defended her company’s pricing policies in an interview published Friday in The New York Times, saying, “I am running a business.”CEO Heather Bresch has come under intense scrutiny in recent weeks over the soaring cost of the company’s popular epinephrine injector, which is used to help counteract life-threatening allergic reactions. The drug has risen in price to around $600 from about $100 in 2009, according to medical literature and GoodRx, which lists...
Share on Facebook
See More...